                </a></li></ul></div><p><strong>Figure 3.  <span>EGFP affects polyubiquitination-dependent processes <strong>
                     <em>in vivo</em>
                  </strong>.</span></strong></p><a id="article1.body1.sec2.fig3.caption1.p1" name="article1.body1.sec2.fig3.caption1.p1"></a><p>(<strong>A</strong>) Western blots of spleen and liver extracts from FVB wild-type (wt) and EGFP transgenic mice detected with antibodies against Ubiquitin, EGFP and actin (loading control).</p>
<a id="article1.body1.sec2.fig3.caption1.p2" name="article1.body1.sec2.fig3.caption1.p2"></a><p>(<strong>B</strong>) EGFP reduces phosphorylation of IκB-α in anti-IgM/anti-CD40 stimulated B-lymphocytes purified from EGFP mice.</p>
<a id="article1.body1.sec2.fig3.caption1.p3" name="article1.body1.sec2.fig3.caption1.p3"></a><p>Experiments performed in triplicate, a representative image of one experiment is shown.</p>
<a id="article1.body1.sec2.fig3.caption1.p4" name="article1.body1.sec2.fig3.caption1.p4"></a><p>The average and standard deviations of ratios of IκB-α-P to actin relative to un-stimulated cells are given.</p>
<a id="article1.body1.sec2.fig3.caption1.p5" name="article1.body1.sec2.fig3.caption1.p5"></a><p>(<strong>C</strong>) The deficit of B220<sup>+</sup>/CD40<sup>+</sup> B-cells in the bone marrow of API2-MALT1 mice is restored in EGFP/API2-MALT1 double transgenic mice.</p>
<a id="article1.body1.sec2.fig3.caption1.p6" name="article1.body1.sec2.fig3.caption1.p6"></a><p>Experiments performed in triplicate, the average and standard deviations are depicted. eMalt1: endogenous Malt1, *a-specific band (<strong>D</strong>) EGFP mice show increased p53 levels in the liver and have enhanced p53/p21 responses upon γ-irradiation induced DNA damage.</p>
<a id="article1.body1.sec2.fig3.caption1.p7" name="article1.body1.sec2.fig3.caption1.p7"></a><p>The average and standard deviations of the ratios of p53/p21 to actin signals relative to that of sample 1 are given.</p>
<a id="article1.body1.sec2.fig3.caption1.p8" name="article1.body1.sec2.fig3.caption1.p8"></a><p>(<strong>E</strong>) Recombinant EGFP (rEGFP) does not prevent polyubiquitination of a Biotin-Lysozyme substrate <em>in vitro</em>. (Ub)<sup>n</sup>: polyubiquitinated proteins.</p>
